Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $9.9600 (-3.77%) ($9.8000 - $12.1900) on Tue. Sep. 3, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.66% (three month average) | RSI | 52 | Latest Price | $9.9600(-3.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -1.1% a day on average for past five trading days. | Weekly Trend | AUTL advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) DRIV(15%) IBB(14%) EWI(13%) IFRA(13%) IWC(13%) | Factors Impacting AUTL price | AUTL will decline at least -2.33% in a week (0% probabilities). VXX(-8%) VIXM(-7%) TLT(-6%) BWX(-2%) SHY(-0%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.33% (StdDev 4.66%) | Hourly BBV | 0 () | Intraday Trend | -3.8% | | | |
|
1 - 5 Day Possible Target | $-15.08(-251.41%) | Resistance Level | $10.96 | 5 Day Moving Average | $10.39(-4.14%) | 10 Day Moving Average | $10.52(-5.32%) | 20 Day Moving Average | $10.96(-9.12%) | To recent high | -48.1% | To recent low | 1.7% | Market Cap | $520m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |